Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
05/20/2010 | WO2010034019A4 Transdermal drug delivery using an osmolyte and vasoactive agent |
05/20/2010 | WO2010018217A3 Purin derivatives for use in the treatment of fab-related diseases |
05/20/2010 | WO2010017369A3 Macromolecular diffusion and release from self-assembled b-hairpin peptide hydrogels |
05/20/2010 | WO2010011466A3 Controlled-release cns modulating compositions and methods for the treatment of otic disorders |
05/20/2010 | WO2010010555A3 Transdermal system for extended delivery of incretins and incretin mimetic peptides |
05/20/2010 | WO2010004287A3 Process for preparing microparticles |
05/20/2010 | WO2009152084A3 Adipose tissue-derived stem cells for veterinary use |
05/20/2010 | WO2009125117A3 Dermatological composition that can be used in particular for the care and prevention of eschars |
05/20/2010 | WO2009097672A3 Pharmaceutical composition, dressing and method for treating skin lesion, intermediate composition and process for preparing said dressing, and use of cerium salt associated with a collagen matrix |
05/20/2010 | WO2009091576A3 Parenteral formulations of dopamine agonists |
05/20/2010 | WO2009040818A9 Compositions comprising lipophilic active compounds and method for their preparation |
05/20/2010 | WO2009033588A3 Self-controlled insulin delivery system |
05/20/2010 | US20100125101 Immunostimulatory nucleic acid molecules |
05/20/2010 | US20100125070 Bupropion Metabolites and Methods of Their Synthesis and Use |
05/20/2010 | US20100125057 Topical skin care composition |
05/20/2010 | US20100124572 Magnetic microsphere and method of forming a microsphere |
05/20/2010 | US20100124571 Use of pH-sensitive, Acid-Stable Metal-Binding Nanoparticles |
05/20/2010 | US20100124570 Highly resilient copolymer with shape recovery force and flexibility and the use thereof for the repair of articular cartilage defects |
05/20/2010 | US20100124569 Amnion derived adherent cells |
05/20/2010 | US20100124568 Pharmaceutical articles coated with lubricious coatings |
05/20/2010 | US20100124567 Stabilizing alkylglycoside compositions and methods thereof |
05/20/2010 | US20100124566 Protection against and treatment of ionizing radiation |
05/20/2010 | US20100124565 Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof |
05/20/2010 | US20100124560 Multi portion intra-oral dosage form and use thereof |
05/20/2010 | US20100124537 Medical applications of alpha-ketoglutarate |
05/20/2010 | US20100124536 Hemophilia Treatment by Inhalation of Coagulation Factors |
05/20/2010 | US20100124535 Aerosol Dispersions of Particles with Active Pharmaceutical Ingredients |
05/20/2010 | US20100122918 Ophthalmic and contact lens solution |
05/20/2010 | DE102008057186A1 Producing mineralized protein hollow body encapsulated with biological and chemical material comprises dissolving primarily produced capsules after protein coating and enzymatic crosslinking and stabilizing remaining protein hollow body |
05/20/2010 | DE102008043724A1 Erhöhung der Effizienz pharmazeutische Wirkstoffe-freisetzender Medizinprodukte durch Kombination mit einem Inhibitor des Transportproteins P-Glycoprotein Increasing the efficiency of active pharmaceutical ingredients eluting medical devices by combination with an inhibitor of the transport protein P-glycoprotein |
05/20/2010 | CA2743901A1 Transdermal systems containing multilayer adhesive matrices to modify drug delivery |
05/20/2010 | CA2743837A1 Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof |
05/20/2010 | CA2743639A1 Solid composition for controlled release of ionizable active agents with poor aqueous solubility at low ph and methods of use thereof |
05/20/2010 | CA2743615A1 Compositions and methods for alleviating hyposalivation and for providing oral comfort |
05/20/2010 | CA2743600A1 Method for preparing microspheres and microspheres produced thereby |
05/20/2010 | CA2743491A1 Inhibition of mammalian target of rapamycin |
05/20/2010 | CA2743469A1 Antibody formulation |
05/20/2010 | CA2743006A1 Inclusion complexes of pinocembrin with cyclodextrin or its derivatives |
05/20/2010 | CA2742846A1 Releasable fusogenic lipids for nucleic acids delivery systems |
05/20/2010 | CA2742449A1 Improved dissolution stability of calcium carbonate tablets |
05/19/2010 | EP2186835A1 Tenside-free cosmetic, dermatological and pharmaceutical medium. |
05/19/2010 | EP2186789A1 Method of producing reduced coenzyme q10 and method of stabilizing the same |
05/19/2010 | EP2186512A1 Use of allylcysteine or its analogs and pharmaceutical composition threrof |
05/19/2010 | EP2186510A2 Matrix compositions for controlled delivery of drug substances |
05/19/2010 | EP2186509A2 Propofol transparent anaesthetic solution with low venous irritation |
05/19/2010 | EP2186508A2 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics |
05/19/2010 | EP2186507A2 A liquid pharmaceutical formulation comprising nicotine for the administration to the oral cavity |
05/19/2010 | EP2185637A1 Biocompatible foams, systems, and methods |
05/19/2010 | EP2185161A2 Silica-based nanoparticles and methods of stimulating bone formation and suppressing bone resorption through modulation of nf-kb |
05/19/2010 | EP2185157A1 Dhea compositions for treating menopause |
05/19/2010 | EP2185147A1 Intranasal pharmaceutical compositions comprising succinic acid and methods thereof |
05/19/2010 | EP2185146A1 Pharmaceutical compositions for intranasal administration comprising choline salts of succinic acid |
05/19/2010 | EP2185139A2 Bupropion hydrobromide and therapeutic applications |
05/19/2010 | EP2185137A1 Carrier-free orodispersible and/or dispersible solid composition with noticeable effect and method for preparing same |
05/19/2010 | EP2185136A2 Oral calcitonin compositions and applications thereof |
05/19/2010 | EP2185134A2 Device for the oral administration of active principles |
05/19/2010 | EP2185132A1 Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same |
05/19/2010 | EP2185131A2 Continuous process for microspheres production by using expanded fluids |
05/19/2010 | EP2185130A2 Tablet containing donepezile hydrochloride in amorphous form |
05/19/2010 | EP2185129A1 Pellet for animals and method for its production |
05/19/2010 | EP1727865B1 Particle-stabilised emulsions |
05/19/2010 | EP1699441B1 Method of manufacture of fast-disintegrating tablets |
05/19/2010 | EP1653815B1 Methods for reducing astringency |
05/19/2010 | EP1463487B1 Liposomal delivery of vitamin e based compounds |
05/19/2010 | EP1435994B1 Novel use of pulmonary surfactant |
05/19/2010 | EP1392242B1 Method of forming an aerosol for inhalation delivery |
05/19/2010 | EP1343510B1 Light stabilized antimicrobial materials |
05/19/2010 | EP1214097B9 Nucleic acids encoding polyepitope polypeptides |
05/19/2010 | EP1115382B1 Immunogenic liposome compositions |
05/19/2010 | CN201469700U Wind-dispelling rod adopting sulphur as main raw materials |
05/19/2010 | CN201469699U Modified plant starch hollow capsule for medicine and food |
05/19/2010 | CN1994425B Soft capsule of 'Sheng Mai' and preparation method thereof |
05/19/2010 | CN1994420B Blood-clearing face-beautifying health product and preparation method thereof |
05/19/2010 | CN1985916B Anaer vagina cleaning effervescent tablet and its production process |
05/19/2010 | CN1981836B Stasis-expelling drop pills for treating coronary heart disease, angina cordis and high blood fat and thereof making method |
05/19/2010 | CN1973901B Composite microsphere preparation of lactic acid-hydroxyacetic acid copolymer and its preparation process |
05/19/2010 | CN1961934B Method for preparing Chinese medicinal wine for treating humerus lateral epicondylitis |
05/19/2010 | CN1957920B Anti cancer slow release agent carrying fluorouracil and synergist |
05/19/2010 | CN1939515B Abstinence Chinese-medicinal preparation and its making method |
05/19/2010 | CN1939343B Bone-peptide sodium chloride injection and its making method |
05/19/2010 | CN1927363B Health food, its preparation method and application |
05/19/2010 | CN1927309B Traditional Chinese medicine composition detection method |
05/19/2010 | CN1927257B Traditional Chinese medicine for treating osteoporosis and its preparation method |
05/19/2010 | CN1927185B Maleic acid trimebutine slow release tablet comprising quick release part and preparing method thereof |
05/19/2010 | CN1927175B Compound recipe anticancer slow release injection comprising tetrazole violet |
05/19/2010 | CN1923173B Anti-cancer drugs slow release agent comprising anticancer antibiotics and synergist thereof |
05/19/2010 | CN1923171B Compound recipe anti-cancer drugs slow release agent comprising anticancer antibiotics and synergist thereof |
05/19/2010 | CN1919174B Anticancer slow release agent including nimustine and its synergist |
05/19/2010 | CN1879688B Preparation for treating wind-heat type cold, its preparation process and quality control method |
05/19/2010 | CN1875936B Anticancer sustained release agent containing clorfarabine and cytotoxic drug |
05/19/2010 | CN1857227B Supercritical fluid aided double circulation process for carrying medicine onto polymer microballoon |
05/19/2010 | CN1631385B Ointment for treating burn and scald and its preparing process |
05/19/2010 | CN101711255A Modified globin proteins with altered electron transport pathway |
05/19/2010 | CN101711174A Controlled release oral formulations of ion channel modulating compounds and related methods for preventing arrhythmia |
05/19/2010 | CN101709073A Nucleotide phospholipid molecule and lipidosome and preparation method and application thereof |
05/19/2010 | CN101709042A Aseptic arginine glutamate and preparation method of powder injection thereof |
05/19/2010 | CN101708339A Nano floxuridine/stratiform thermometal hydroxide hybrid and preparation method thereof |
05/19/2010 | CN101708338A Prodrug containing sterides structures and high dispersion preparation thereof |
05/19/2010 | CN101708337A Preparation method of human serum albumin nano granules coated with oxaliplatin |
05/19/2010 | CN101708336A Novel medicinal premixing auxiliary material |